Literature DB >> 2900363

Effect of antischistosomal chemotherapy on prevalence of Symmers' periportal fibrosis in Sudanese villages.

M A Homeida1, A Fenwick, A A DeFalla, S Suliman, M W Kardaman, I el Tom, T Nash, J L Bennett.   

Abstract

Almost all mortality caused by Schistosoma mansoni is secondary to Symmers' periportal fibrosis of the liver which can now be diagnosed by ultrasonography. This study assessed the usefulness of ultrasonography in measuring the effect of chemotherapy on the prevalence of Symmers' periportal fibrosis in Sudanese villagers. The prevalence of Symmers' fibrosis in 318 randomly selected patients from two villages not receiving systemic antischistosomal chemotherapy was compared with that in 168 patients from a village where antischistosomal chemotherapy had been systematically applied since 1979. The prevalence of Symmers' fibrosis was two to three times lower among treated villagers, with an eight-fold difference for villagers aged 10-20 years.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2900363     DOI: 10.1016/s0140-6736(88)90424-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  8 in total

Review 1.  The cost effectiveness of mass drug therapy for intestinal helminths.

Authors:  D B Evans; H L Guyatt
Journal:  Pharmacoeconomics       Date:  1995-07       Impact factor: 4.981

Review 2.  Anthelminthic agents: some recent developments and their clinical application.

Authors:  G C Cook
Journal:  Postgrad Med J       Date:  1991-01       Impact factor: 2.401

Review 3.  Tropical medicine.

Authors:  G C Cook
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

Review 4.  The WHO ultrasonography protocol for assessing hepatic morbidity due to Schistosoma mansoni. Acceptance and evolution over 12 years.

Authors:  Tarik el Scheich; Martha C Holtfreter; Hendrik Ekamp; Daman D Singh; Rodrigo Mota; Christoph Hatz; Joachim Richter
Journal:  Parasitol Res       Date:  2014-09-27       Impact factor: 2.289

5.  Schistosomiasis mansoni in Burundi: progress in its control since 1985.

Authors:  D Engels; J Ndoricimpa; B Gryseels
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

Review 6.  Anthelmintics. A comparative review of their clinical pharmacology.

Authors:  N de Silva; H Guyatt; D Bundy
Journal:  Drugs       Date:  1997-05       Impact factor: 9.546

7.  Characterization of the murine model of schistosomal hepatic periportal fibrosis ('pipestem' fibrosis).

Authors:  Z A Andrade; A W Cheever
Journal:  Int J Exp Pathol       Date:  1993-04       Impact factor: 1.925

8.  Regression of Schistosoma mansoni associated morbidity among Ugandan preschool children following praziquantel treatment: A randomised trial.

Authors:  Allen Nalugwa; Edridah Muheki Tukahebwa; Annette Olsen; Fred Nuwaha
Journal:  PLoS One       Date:  2021-11-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.